Needle Gauge and Length for TRT and Peptide Injections (25G to 31G)

Two numbers describe every needle: the gauge, which is its thickness, and the length. They answer different questions. Gauge decides how fast the liquid moves and how much the insertion is felt; length decides which tissue layer the dose ends up in. This guide explains both, with the ranges nursing texts and the CDC actually publish.

Short answer: the gauge (G) is the needle's diameter, and a higher number means a thinner needle. For subcutaneous peptide or testosterone injections, nursing references give a range of 25–31 gauge at ½–⅝ inch long; for intramuscular injections they give needles up to 1½ inches, with 18–21 gauge listed for oily or viscous solutions and 20–25 gauge for watery ones^2,3. The CDC's adult vaccine table uses 22–25 gauge and sets deltoid length by body weight⁴. Gauge controls flow and comfort; length controls which layer the dose lands in.

This is a reference to what the numbers mean, not a prescription. Whoever prescribes your medication, or the nurse who trains you, should tell you which needles to use. For the injection steps themselves, see how to inject testosterone and how to inject peptides.

How needle gauge works

A needle has three parts: the hub that attaches to the syringe, the shaft, and the slanted tip called the bevel¹. Gauge describes the shaft's diameter. The OpenRN nursing textbook describes needles from small diameter (25 to 29 gauge) to large diameter (18 to 22 gauge) and states the rule plainly: the larger the diameter, the smaller the gauge number¹. So a 31G insulin-syringe needle is much finer than a 23G needle, and an 18G needle is wider than both.

The same textbook gives needle lengths from about ⅛ inch to 3 inches, chosen by the type of injection¹. Package labels usually print both numbers together, for example "25G × ⅝ in" or "27G × ½ in". Read them as two separate choices: the first is about the liquid and your comfort, the second is about your anatomy.

Gauge and length by job: the published ranges

Two things stand out. First, the SubQ range covers the fine fixed needles on insulin syringes, which is why they are often used for SubQ peptides. Second, nursing texts list wider gauges for oily IM medications (18–21G) than the CDC's range for watery vaccines (22–25G). Finer needles can still deliver oil, just more slowly, as explained below.

Drawing needle vs injecting needle

With a detachable-needle syringe, the needle that pulls liquid out of the vial does not have to be the one that goes into you. Nursing guidance for glass ampules uses a blunt fill filter needle to draw, and is explicit that it should never be used to inject; it is removed and replaced with a needle of the right size and gauge for the injection¹. A similar two-needle habit is commonly taught for oil-based testosterone: a wide needle pulls the thick oil out of the vial quickly, and a fresh, finer needle is fitted for the injection.

Insulin syringes are different: the needle is permanently attached, so you draw and inject with the same fine needle. That is fine for watery reconstituted peptides. It is slow with oil, which is one reason SubQ testosterone users often use a detachable syringe for drawing.

Why thin needles draw oil slowly

Testosterone cypionate is dissolved in cottonseed oil: the Depo-Testosterone label lists 736 mg of cottonseed oil per mL in the 100 mg/mL strength and 560 mg per mL in the 200 mg/mL strength, along with benzyl benzoate and benzyl alcohol¹⁰. Oil is thicker than the water-based liquids most needle guidance is written for, which is why nursing texts assign 18–21 gauge to oily IM injections³.

Force is the other side of it. In a laboratory study of syringe and needle combinations, higher-gauge (thinner) needles needed significantly more force to push liquid through, and the combination of a 10 mL syringe with a 30G needle needed the most⁸. A small-barrel syringe with a finer needle feels easier than a big barrel with the same needle, but the thin needle still sets the pace.

That does not make fine needles unusable with oil; it makes them slow. A review of subcutaneous testosterone notes that a 23-gauge needle can be used without difficulty for long- and ultralong-acting esters, and recommends a Luer-Lok syringe because of the solution's viscosity⁹. Drawing with a wider needle and swapping it before the injection is the usual workaround. If injecting through the needle you were given is a struggle, ask your prescriber about the gauge rather than forcing the plunger.

Does a thinner needle hurt less?

On average, yes. In a controlled study using an automated insertion device, 63% of insertions with a 23G needle were painful, compared with 53% at 27G and 31% at 32G, and the thickest needle caused the most insertions that bled⁶. A review in the Journal of Diabetes Science and Technology reports a similar pattern: 27- or 28-gauge insertions had about a 50% chance of being reported as painful, versus 39% for 31-gauge⁷.

The same review adds the trade-off: smaller needles are not suitable for everything, and rapid delivery of large volumes needs larger needles⁷. For an injection of a few tenths of a millilitre of watery peptide solution, a fine insulin-syringe needle does the job. For 1 mL of oil into a muscle, the finest possible needle mostly buys you a longer push.

Needle length: getting to the right layer

Length is chosen so the tip finishes in the intended layer. An ultrasound study of 388 adults with diabetes found average skin thickness of about 2 mm at the arm, thigh, abdomen and buttock, while the subcutaneous fat layer averaged roughly 10–15 mm and varied far more: women had about 5 mm more fat than men, and every 10 kg/m² of BMI accounted for about 4 mm⁵. The authors concluded that 4–5 mm needles inserted at 90° reach subcutaneous tissue with minimal risk of hitting muscle in virtually all adults, while needles of 8 mm or longer may often reach muscle in the limbs of men and people with a BMI under 25⁵.

Subcutaneous injections

The OpenRN textbook gives ½–⅝ inch for SubQ needles, an angle of 90° for average or larger adults and 45° for thin people with little fat at the site, a pinch of skin during insertion, and a limit of 1 mL per adult SubQ injection². For peptides this usually means an insulin syringe at 90° into a pinch of abdominal fat. The insulin syringe units guide covers the markings, barrel sizes and how to convert units to millilitres.

Intramuscular injections by site

IM needles must pass through the fat and finish in muscle, so length tracks both site and build. The figures below are from the OpenRN nursing text and the CDC; each site guide goes into landmarks and volume in more detail.

The CDC notes that length should be chosen with clinical judgment based on age, weight, sex, muscle development and site⁴, and the weight bands in its table are a starting point rather than a rule. Someone lean and muscular may need a shorter needle than their weight suggests; someone who carries fat on the hips may need a longer one at the ventrogluteal site. For a side-by-side of the sites, see the injection sites and rotation guide.

TRT and peptides: typical needle combinations

If you are weighing SubQ against IM for testosterone in the first place, the SubQ vs IM comparison covers blood levels, dose and comfort.

Dead space: why the needle design matters for small doses

Dead space is the fluid left in the hub and needle after the plunger is fully pressed. It varies a lot by design. Measurements of 56 needle and syringe combinations found an average of about 3 μL in low dead space syringes with permanently attached needles, 13 μL with high dead space syringes and low dead space needles, 45 μL with low dead space syringes and high dead space needles, and 99 μL when both were high dead space¹¹.

For a 20-unit (0.2 mL) peptide dose, 3 μL is negligible, but 99 μL is half as much again, which is lost with every injection. Fixed-needle insulin syringes sit at the low end, which is one practical reason they suit small peptide volumes. Dead space is also why you should draw and read your dose with the same syringe you inject with, and not transfer liquid between syringes. The insulin syringe guide has more on reading small volumes accurately.

Common needle mistakes

1. Reading the gauge scale the wrong way round. 31G is the thinnest needle in this guide, not the thickest.
2. Injecting with the needle that went through the vial stopper, especially when that needle was a wide drawing needle.
3. Using a SubQ-length needle for an IM shot. A ½-inch needle into the hip of an adult with average or larger fat stores will likely deposit oil in fat, not muscle^3,5.
4. Using a long needle at 90° for SubQ in a lean area. In lean people and men's limbs, needles of 8 mm or longer can reach muscle⁵; a shorter needle or a pinch fixes it.
5. Forcing oil through a very fine needle and bending it or popping the needle off a slip-tip syringe. A Luer-Lok syringe is recommended for oil for this reason⁹.
6. Reusing needles. A needle is single-use; the tip dulls after one pass and it is no longer sterile.

Tracking what you used

If you change gauge, length or site and notice a difference in soreness, lumps or leakage, it helps to have written it down. Peptide Me logs each injection with the site on a body map, so you can look back at what you used when an injection went well, and bring that record to your next appointment.

Disclaimer: this guide summarises published nursing and CDC guidance on needles and is not medical advice. The needle gauge, length and injection site are part of your prescription; ask your prescriber or nurse which to use and to show you the technique in person.

FAQ

References

Primary sources — PubMed / NEJM / The Lancet.

1. Ernstmeyer K, Christman E, eds. Nursing Skills (Open RN), Chippewa Valley Technical College. Chapter 18.2: Basic Concepts (Administration of Parenteral Medications). https://med.libretexts.org/Bookshelves/Nursing/Nursing_Skills_(OpenRN)/18%3A_Administration_of_Parenteral_Medications/18.02%3A_Basic_Concepts
2. Ernstmeyer K, Christman E, eds. Nursing Skills (Open RN), Chippewa Valley Technical College. Chapter 18.5: Administering Subcutaneous Medications. https://med.libretexts.org/Bookshelves/Nursing/Nursing_Skills_(OpenRN)/18%3A_Administration_of_Parenteral_Medications/18.05%3A_Administering_Subcutaneous_Medications
3. Ernstmeyer K, Christman E, eds. Nursing Skills (Open RN), Chippewa Valley Technical College. Chapter 18.6: Administering Intramuscular Medications. https://med.libretexts.org/Bookshelves/Nursing/Nursing_Skills_(OpenRN)/18%3A_Administration_of_Parenteral_Medications/18.06%3A_Administering_Intramuscular_Medications
4. Centers for Disease Control and Prevention. Chapter 6: Vaccine Administration. In: Epidemiology and Prevention of Vaccine-Preventable Diseases (Pink Book). https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-6-vaccine-administration.html
5. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519-1530. https://pubmed.ncbi.nlm.nih.gov/20429833/
6. Arendt-Nielsen L, Egekvist H, Bjerring P. Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res. 2006;23(1-2):37-43. https://pubmed.ncbi.nlm.nih.gov/16846958/
7. Gill HS, Prausnitz MR. Does needle size matter? J Diabetes Sci Technol. 2007;1(5):725-729. https://pmc.ncbi.nlm.nih.gov/articles/PMC2769648/
8. Prasetyono TOH, Adhistana P. Laboratory Study on Injection Force Measurement on Syringe and Needle Combinations. Malays J Med Sci. 2019;26(2):66-76. https://pmc.ncbi.nlm.nih.gov/articles/PMC6687218/
9. Figueiredo MG, Gagliano-Jucá T, Basaria S. Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option. J Clin Endocrinol Metab. 2022;107(3):614-626. https://pmc.ncbi.nlm.nih.gov/articles/PMC9006970/
10. DailyMed. DEPO-TESTOSTERONE (testosterone cypionate) injection, solution — Prescribing Information. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cfbb53d4-b868-4a28-8436-f9112eb01c39
11. Zule WA, Pande PG, Otiashvili D, et al. Options for reducing HIV transmission related to the dead space in needles and syringes. Harm Reduct J. 2018;15(1):3. https://pmc.ncbi.nlm.nih.gov/articles/PMC5769352/